文献速递口腔修复与种植

骨质疏松/骨量减少女性种植体治疗5年前瞻性对照多中心研究

A Prospective, Controlled, Multicenter Study to Evaluate the Clinical Outcome of Implant Treatment in Women with Osteoporosis/Osteopenia: 5-Year Results.
PubMed 文献 · J Dent Res · 2018-09-11

针对绝经后需种植的女性,按髋/脊柱双能X线吸收法T值分组:骨质疏松组(T≤-2)与对照组(T≥-1)。共48例患者植入148枚种植体,5年随访评估种植体存留率与边缘骨水平变化,比较两组长期临床结局。

要点

  • 骨质疏松组5年种植体累积存留率91.5%,对照组100.0%(P<0.05)。
  • 患者水平存留率两组差异无统计学意义(P>0.05)。
  • 5年边缘骨水平变化两组间无显著差异(P>0.05)。

核心结论

  • 骨质疏松患者接受口腔种植治疗是可靠选择,5年功能负载后骨结合率、种植体存留率及边缘骨水平变化与对照组相当。

研究设计与样本

  • 前瞻性、对照、多中心研究,纳入需种植的绝经后女性,按髋和脊柱双能X线吸收法T值分为骨质疏松组(T≤-2)与对照组(T≥-1)。
  • 种植体采用两阶段方式植入,基台手术后4-8周负载;负载后6个月及之后每年评估临床和影像学参数。
  • 5年后评估37例患者共117枚种植体(骨质疏松组38枚,对照组79枚)。

主要发现

  • 种植体水平累积存留率总体96.5%,骨质疏松组91.5%,对照组100.0%(P<0.05)。
  • 患者水平累积存留率总体95.7%,骨质疏松组89.2%,对照组100.0%(P>0.05)。
  • 负载5年后总体边缘骨水平变化为-0.09±0.78 mm(种植体水平),骨质疏松组-0.15±0.50 mm,对照组-0.06±0.89 mm。
  • 患者水平边缘骨水平变化总体-0.09±0.54 mm,骨质疏松组-0.18±0.43 mm,对照组0.06±0.58 mm(P>0.05)。

临床怎么用

  • 对绝经后骨质疏松/骨量减少女性,种植治疗可获得可靠的5年存留与骨结合效果,但骨质疏松组种植体水平存留率略低,需加强随访。

局限性

  • 5年随访时仅评估37例患者117枚种植体,存在失访;原文未报告失访原因及对结果的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The impact of osteoporosis on implant treatment is still a matter of debate in the scientific community, as it may possibly lead to higher failure rates. As long-term controlled trials are missing, the aim of this study was to verify the long-term outcome of implants placed in patients with systemic osteoporosis. Postmenopausal women in need of implants underwent bone mineral density measurements in hip and spine, using dual X-ray absorptiometry scans. Based on T-scores, they were divided into 2 groups: group O (osteoporosis group) with a T-score ≤-2 or group C (control group) with a T-score of ≥-1. Implants were placed in a 2-stage manner and loaded 4 to 8 wk after abutment surgery. Six months after loading and thereafter yearly, clinical and radiographical parameters were assessed. In total, 148 implants were placed in 48 patients (mean age: 67 y [range, 59-83]). Sixty-three implants were placed in 20 patients (group O) and 85 implants in 28 patients (group C). After 5 y, 117 implants (38 in group O and 79 in the group C) in 37 patients were assessed. Cumulative survival rate on an implant level was 96.5% (group O: 91.5%; group C: 100.0% [ P < 0.05]) and 95.7% (group O: 89.2%; group C: 100.0% [ P > 0.05]) on a patient level. The overall marginal bone-level alterations, after 5 y of loading, were -0.09 ± 0.78 mm (group O: -0.15 ± 0.50 mm; group C: -0.06 ± 0.89 mm) on an implant level and -0.09 ± 0.54 mm (group O: -0.18 ± 0.43 mm; group C: 0.06 ± 0.58 mm) on a patient level ( P > 0.05). Oral implant therapy in osteoporotic patients is a reliable treatment option with comparable osseointegration rates, implant survival, and marginal bone-level alterations after 5 y of functional loading (ClinicalTrials.gov NCT00745121).

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Temmerman A, Rasmusson L, Kübler A, et al. A Prospective, Controlled, Multicenter Study to Evaluate the Clinical Outcome of Implant Treatment in Women with Osteoporosis/Osteopenia: 5-Year Results. J Dent Res. 2018. PMID: 30205020. doi:10.1177/0022034518798804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。